A2BCD: a concise guide for asthma management

M Lommatzsch, GG Brusselle, ML Levy… - The Lancet …, 2023 - thelancet.com
The management of asthma has changed fundamentally during the past two decades.
Precise assessment and phenotyping are now required to establish individually targeted …

[HTML][HTML] Update on the role of FeNO in asthma management

N Murugesan, D Saxena, A Dileep, M Adrish… - Diagnostics, 2023 - mdpi.com
Asthma is a heterogenous disorder characterized by presence of different phenotypes and
endotypes. Up to 10% of the individuals suffer from severe asthma and are at increased risk …

[HTML][HTML] S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023

M Lommatzsch, CP Criée, CCM de Jong… - …, 2023 - thieme-connect.com
Das Management von Asthma hat sich in den letzten Jahrzehnten fundamental gewandelt.
Die vorliegende Leitlinie zur Diagnostik und Therapie von Asthma wurde für pneumologisch …

Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases

B Ragnoli, A Radaeli, P Pochetti… - … in Chronic Disease, 2023 - journals.sagepub.com
Exhaled nitric oxide (NO) production, upregulated by inflammatory cytokines and mediators
in central and peripheral airways, can be easily and non-invasively detected in exhaled air …

Cough and cough hypersensitivity as treatable traits of asthma

K Lai, I Satia, WJ Song, G Wang, A Niimi… - The Lancet …, 2023 - thelancet.com
Cough is a common and troublesome symptom in people with asthma and is often
associated with poorer asthma control and exacerbations. Apart from asthma, other causes …

[HTML][HTML] Eosinophilic asthma, phenotypes-endotypes and current biomarkers of choice

K Porpodis, I Tsiouprou, A Apostolopoulos… - Journal of Personalized …, 2022 - mdpi.com
Asthma phenotyping and endotyping are constantly evolving. Currently, several biologic
agents have been developed towards a personalized approach to asthma management …

Narrative review of the mechanisms and treatment of cough in asthma, cough variant asthma, and non-asthmatic eosinophilic bronchitis

N Diab, M Patel, P O'Byrne, I Satia - Lung, 2022 - Springer
Chronic cough is a debilitating condition affecting 10–12% of the general population and is
one of the leading causes for referral to secondary care. Many conditions have been …

Questions in mild asthma: an official American Thoracic Society research statement

A Mohan, NL Lugogo, NA Hanania… - American journal of …, 2023 - atsjournals.org
Background: Patients with mild asthma are believed to represent the majority of patients with
asthma. Disease-associated risks such as exacerbations, lung function decline, and death …

[PDF][PDF] British Thoracic Society Clinical Statement on chronic cough in adults

SM Parker, JA Smith, SS Birring… - thorax, 2023 - pure.qub.ac.uk
British Thoracic Society clinical statement on chronic cough in adults Page 1 British
Thoracic Society clinical statement on chronic cough in adults Parker, SM, Smith, JA, Birring …

ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (FENO50)

M Högman, C Bowerman, L Chavez… - European …, 2024 - Eur Respiratory Soc
Background Elevated exhaled nitric oxide fraction at a flow rate of 50 mL· s− 1 (F ENO50) is
an important indicator of T-helper 2-driven airway inflammation and may aid clinicians in the …